With this issuance, these ZYN nicotine pouch products which have been authorized for sale in the United States since January 2025 may now be marketed with the following risk modification claim: "Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis." FDA authorizes 20 ZYN nicotine pouches be marketed with modified risk claim Dig deeper: An order permitting the sale of a modified risk tobacco product (MRTP) refers to specific products, not an entire class of tobacco products
Embrace her effortless daytime style with these wide-leg jeans and classic turtleneck for a timeless off-duty outfit
It was much worse than the alcohol, he added, saying it took him forever to quit
[50] [51] Synthetic cannabinoids are increasingly offered in e-cigarette form as "c-liquid"
Signs of a reaction include sneezing, coughing, wheezing, labored breathing, nasal discharge, and itchy eyes